Skip to main content

Table 1 Distribution of patients between treatment sequences

From: Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Sequence Allocation ratio Treatments Delivery device
   Period 1 Period 2 Period 3  
1 7 Placebo FF 200 μg OD FF 100 μg BD Novel dry powder inhaler
2 7 Placebo FF 100 μg BD FF 200 μg OD  
3 7 FF 100 μg BD Placebo FF 200 μg OD  
4 7 FF 100 μg BD FF 200 μg OD Placebo  
5 7 FF 200 μg OD Placebo FF 100 μg BD  
6 7 FF 200 μg OD FF 100 μg BD Placebo  
7 2 Placebo FP 200 μg OD FP 100 μg BD Diskus™ inhaler
8 2 Placebo FP 100 μg BD FP 200 μg OD  
9 2 FP 100 μg BD Placebo FP 200 μg OD  
10 2 FP 100 μg BD FP 200 μg OD Placebo  
11 2 FP 200 μg OD Placebo FP 100 μg BD  
12 2 FP 200 μg OD FP 100 μg BD Placebo  
  1. FF = fluticasone furoate; FP = fluticasone propionate; BD = twice daily;
  2. OD = once daily.